165 related articles for article (PubMed ID: 25153575)
1. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial.
Uchiyama A; Kushima R; Watanabe T; Kusuda S
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):177-82. PubMed ID: 25153575
[TBL] [Abstract][Full Text] [Related]
2. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
[TBL] [Abstract][Full Text] [Related]
3. Thyroxine for transient hypothyroxinemia and cerebral palsy in extremely preterm infants.
Suzumura H; Nitta A; Tsuboi Y; Watabe Y; Kuribayashi R; Arisaka O
Pediatr Int; 2011 Aug; 53(4):463-7. PubMed ID: 21054676
[TBL] [Abstract][Full Text] [Related]
4. Effect of L-thyroxine supplementation on very low birth weight infants with transient hypothyroxinemia of prematurity at 3 years of age.
Uchiyama A; Kushima R; Watanabe T; Kusuda S
J Perinatol; 2017 May; 37(5):602-605. PubMed ID: 28125093
[TBL] [Abstract][Full Text] [Related]
5. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between hypothyroxinemia of prematurity and transient thyroid abnormalities with adverse long term neurodevelopmental outcome in very low birth weight infants.
Tan LO; Tan MG; Poon WB
PLoS One; 2019; 14(9):e0222018. PubMed ID: 31513612
[TBL] [Abstract][Full Text] [Related]
7. Hypothyroxinemia in premature infants: is thyroxine treatment necessary?
Fisher DA
Thyroid; 1999 Jul; 9(7):715-20. PubMed ID: 10447019
[TBL] [Abstract][Full Text] [Related]
8. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease.
Matsuura N; Harada S; Ohyama Y; Shibayama K; Fukushi M; Ishikawa N; Yuri K; Nakanishi M; Yokota Y; Kazahari K; Oguchi H
Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225
[TBL] [Abstract][Full Text] [Related]
9. Initial and delayed thyroid-stimulating hormone elevation in extremely low-birth-weight infants.
Yoon SA; Chang YS; Ahn SY; In Sung S; Park WS
BMC Pediatr; 2019 Oct; 19(1):347. PubMed ID: 31604459
[TBL] [Abstract][Full Text] [Related]
10. Relationship between free T4 levels and postnatal steroid therapy in preterm infants.
Arai H; Goto R; Matsuda T; Takahashi T
Pediatr Int; 2009 Dec; 51(6):800-3. PubMed ID: 19419509
[TBL] [Abstract][Full Text] [Related]
11. Thyroid dysfunctions of prematurity and their impacts on neurodevelopmental outcome.
Chung ML; Yoo HW; Kim KS; Lee BS; Pi SY; Lim G; Kim EA
J Pediatr Endocrinol Metab; 2013; 26(5-6):449-55. PubMed ID: 23412858
[TBL] [Abstract][Full Text] [Related]
12. Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth.
Jones JH; Gellén B; Paterson WF; Beaton S; Donaldson MD
Arch Dis Child; 2008 Nov; 93(11):940-4. PubMed ID: 18456702
[TBL] [Abstract][Full Text] [Related]
13. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia.
Chowdhry P; Scanlon JW; Auerbach R; Abbassi V
Pediatrics; 1984 Mar; 73(3):301-5. PubMed ID: 6366725
[TBL] [Abstract][Full Text] [Related]
14. The influence of amino-acid supplementation, gestational age and time on thyroxine levels in premature neonates.
Kelleher AS; Clark RH; Steinbach M; Chace DH; Spitzer AR;
J Perinatol; 2008 Apr; 28(4):270-4. PubMed ID: 18288119
[TBL] [Abstract][Full Text] [Related]
15. Does transient hypothyroxinemia influence metabolic bone disease of prematurity?
Demirel U; Özek E; Bereket A; Demirel B; Topuzoğlu A; Akman İ
J Matern Fetal Neonatal Med; 2013 Dec; 26(18):1844-9. PubMed ID: 23672243
[TBL] [Abstract][Full Text] [Related]
16. Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine.
Peroni E; Vigone MC; Mora S; Bassi LA; Pozzi C; Passoni A; Weber G
Horm Res Paediatr; 2014; 81(1):50-4. PubMed ID: 24247169
[TBL] [Abstract][Full Text] [Related]
17. Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes.
Woo HC; Lizarda A; Tucker R; Mitchell ML; Vohr B; Oh W; Phornphutkul C
J Pediatr; 2011 Apr; 158(4):538-42. PubMed ID: 21232766
[TBL] [Abstract][Full Text] [Related]
18. The thyroid-system function in preterm infants of postmenstrual ages of 31 weeks or less: evidence for a "transient lazy thyroid system".
Eggermont E; Vanderschueren-Lodeweyckx M; De Nayer P; Smeets E; Vanacker G; Cornette C; Jaeken J; Devlieger H; Eeckels R; Beckers C
Helv Paediatr Acta; 1984 Aug; 39(3):209-22. PubMed ID: 6544306
[TBL] [Abstract][Full Text] [Related]
19. In congenital hypothyroidism, an initial L-thyroxine dose of 10-12 μg/kg/day is sufficient and sometimes excessive based on thyroid tests 1 month later.
Vaidyanathan P; Pathak M; Kaplowitz PB
J Pediatr Endocrinol Metab; 2012; 25(9-10):849-52. PubMed ID: 23426811
[TBL] [Abstract][Full Text] [Related]
20. Transient hypothyroxinemia of prematurity is associated with abnormal cranial ultrasound and illness severity.
Huang CB; Chen FS; Chung MY
Am J Perinatol; 2002 Apr; 19(3):139-47. PubMed ID: 12012289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
